Annual Total Long Term Liabilities
$66.90 K
-$83.70 K-55.58%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual total long term liabilities is $66.90 thousand, with the most recent change of -$83.70 thousand (-55.58%) on December 31, 2023.
- During the last 3 years, PCSA annual total long term liabilities has fallen by -$987.10 thousand (-93.65%).
- PCSA annual total long term liabilities is now -96.96% below its all-time high of $2.20 million, reached on December 31, 2011.
Performance
PCSA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2200.00
-$23.40 K-91.41%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly total long term liabilities is $2200.00, with the most recent change of -$23.40 thousand (-91.41%) on September 30, 2024.
- Over the past year, PCSA quarterly long term liabilities has dropped by -$48.50 thousand (-95.66%).
- PCSA quarterly long term liabilities is now -99.92% below its all-time high of $2.76 million, reached on March 31, 2018.
Performance
PCSA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PCSA Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -55.6% | -95.7% |
3 y3 years | -93.7% | -98.5% |
5 y5 years | -96.9% | -98.5% |
PCSA Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -55.6% | +804.0% | -98.7% | at low |
5 y | 5-year | -96.0% | +804.0% | -99.9% | at low |
alltime | all time | -97.0% | -100.0% | -99.9% | -100.0% |
Processa Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2200.00(-91.4%) |
Jun 2024 | - | $25.60 K(-49.5%) |
Mar 2024 | - | $50.70 K(-24.2%) |
Dec 2023 | $66.90 K(-55.6%) | $66.90 K(-24.7%) |
Sep 2023 | - | $88.80 K(-18.8%) |
Jun 2023 | - | $109.30 K(-15.5%) |
Mar 2023 | - | $129.40 K(-14.1%) |
Dec 2022 | $150.60 K(+1935.1%) | $150.60 K(-12.3%) |
Sep 2022 | - | $171.70 K(+3553.2%) |
Jun 2022 | - | $4700.00(-23.0%) |
Mar 2022 | - | $6100.00(-17.6%) |
Dec 2021 | $7400.00(-99.3%) | $7400.00(-98.7%) |
Sep 2021 | - | $590.50 K(-19.7%) |
Jun 2021 | - | $735.10 K(-18.9%) |
Mar 2021 | - | $906.40 K(-14.0%) |
Dec 2020 | $1.05 M(-37.2%) | $1.05 M(-24.9%) |
Sep 2020 | - | $1.40 M(-7.7%) |
Jun 2020 | - | $1.52 M(-0.7%) |
Mar 2020 | - | $1.53 M(-8.8%) |
Dec 2019 | $1.68 M(-21.3%) | $1.68 M(-9.7%) |
Sep 2019 | - | $1.86 M(-8.0%) |
Jun 2019 | - | $2.02 M(-9.4%) |
Mar 2019 | - | $2.23 M(+4.5%) |
Dec 2018 | $2.13 M | $2.13 M(-5.8%) |
Sep 2018 | - | $2.27 M(-8.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2018 | - | $2.48 M(-10.2%) |
Mar 2018 | - | $2.76 M(>+9900.0%) |
Dec 2017 | $10.00 K(>+9900.0%) | $10.00 K(>+9900.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2015 | - | $27.50 K(-73.8%) |
Jun 2015 | - | $104.90 K(-12.1%) |
Mar 2015 | - | $119.40 K(-75.8%) |
Dec 2014 | $494.10 K(+239.6%) | $494.10 K(-75.0%) |
Sep 2014 | - | $1.97 M(+23.4%) |
Jun 2014 | - | $1.60 M(+46.3%) |
Mar 2014 | - | $1.09 M(+651.5%) |
Dec 2013 | $145.50 K(-76.0%) | $145.50 K(-6.9%) |
Sep 2013 | - | $156.20 K(+69.2%) |
Jun 2013 | - | $92.30 K(-73.6%) |
Mar 2013 | - | $349.20 K(-42.4%) |
Dec 2012 | $606.20 K(-72.4%) | $606.20 K(-45.6%) |
Sep 2012 | - | $1.11 M |
Dec 2011 | $2.20 M | - |
FAQ
- What is Processa Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Processa Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Processa Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of PCSA is $66.90 K
What is the all time high annual total long term liabilities for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual total long term liabilities is $2.20 M
What is Processa Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, PCSA annual total long term liabilities has changed by -$83.70 K (-55.58%)
What is Processa Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of PCSA is $2200.00
What is the all time high quarterly long term liabilities for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly total long term liabilities is $2.76 M
What is Processa Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, PCSA quarterly total long term liabilities has changed by -$48.50 K (-95.66%)